Skip to main content

Table 3 Odds Ratio (95% confidence interval) of socio-demographic and clinical predictors with the presence of complications and poor glycemic control

From: Age differences in diabetes-related complications and glycemic control

Characteristics

Poor Glycemic Control

Presence of Complications

OR1 (95% CI)

OR2 (95% CI)

OR3 (95% CI)

OR1 (95% CI)

OR2 (95% CI)

OR3 (95% CI)

Age group

  ≤ 49

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

 50–59

0.62 (0.39–0.98)

0.57 (0.35–0.94)

0.49 (0.28–0.86)

1.63 (1.10–2.42)

1.53 (1.00–2.33)

1.13 (0.67–1.90)

  ≥ 60

0.72 (0.44–1.15)

0.51 (0.30–0.87)

0.44 (0.24–0.80)

2.23 (1.48– 3.37)

2.24 (1.41–3.54)

1.74 (1.00–3.02)

P value

0.119

0.039

0.020

0.001

0.003

0.076

Sex

 Male

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

 Female

0.93 (0.65– 1.34)

1.25 (0.82–1.92)

0.73 (0.45–1.18)

1.52 (1.09–2.11)

1.57 (1.08–2.28)

1.15 (0.73 –1.82)

P value

0.699

0.304

0.198

0.013

0.019

0.560

Education

 Illiterate

1.32 (0.85 –2.04)

1.07 (0.63 –1.82)

1.20 (0.67 –2.17)

1.79 (1.22 –2.63)

1.39 (0.88–2.20)

1.96 (1.12–3.45)

 Primary school

0.68 (0.44 – 1.06)

0.64 (0.39– 1.03)

0.75 (0.44–1.26)

1.60 (1.07 –2.40)

1.58 (1.03–2.42)

1.91 (1.14 –3.20)

 Secondary school & higher

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

P value

0.003

0.037

0.152

0.01

0.114

0.027

Income

 Low <1000,000 Tomans

2.72 (1.90–3.89)

2.56 (1.75–3.76)

2.56 (1.68–3.90)

1.05 (0.75–1.46)

1.01 (0.76–1.44)

1.04 (0.68–1.60)

 Acceptable

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

P value

<0.001

<0.001

<0.001

0.775

0.976

0.860

Duration of disease

  ≤ 3 years

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

 4–7

0.68 (0.41–1.13)

0.65 (0.37–1.13)

0.88 (0.48–1.63)

1.91 (1.17–3.13)

1.99 (1.16–3.42)

2.98 (1.54–5.76)

  > 7 years

1.34 (0.85–2.10)

1.49 (0.91–2.45)

1.55 (0.90–2.65)

4.23 (2.75–6.51)

4.55 (2.82–7.33)

7.25 (4.00–13.12)

P value

0.004

0.001

0.043

<0.001

<0.001

<0.001

BMI

  < 25

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

 25–29.9

1.30 (0.80–2.11)

1.28 (0.75–2.16)

1.92 (0.85–4.36)

1.19 (0.77–1.84)

1.20 (0.75–1.90)

1.42 (0.83–2.42)

  ≥ 30

0.96 (0.59–1.54)

089 (0.52–1.52)

1.05 (0.45–2.45)

1.60 (1.04–2.47)

1.42 (0.89–2.27)

1.66 (0.97–2.84)

P value

0.274

0.246

0.118

0.067

0.326

0.181

Total Cholesterol

Desirable

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

  ≥ 240

5.90 (2/07 –16.84)

5.95 (1.76–20.14)

4.54 (1.29 –15.94)

0.84 (0.45–1/56)

0.93 (0.45–1.90)

1.30 (0.52–3.22)

P value

0.001

0.004

0.018

0.573

0.840

0.887

Hypertension

Controlled

Ref group

Ref group

Ref group

Ref group

Ref group

Ref group

 Uncontrolled

1.71 (1.22–2.40)

1.57 (1.09–2.26)

1.49 (1.00–2.22)

0.99 (0.73–1.35)

1.02 (0.73–1.41)

0.83 (0.56–1.23)

P value

0.002

0.016

0.052

0.963

0.929

0.354

  1. OR1: Crude. OR2: Adjusted for age, gender, education and income. OR3: Adjusted for age, gender, education, income, disease duration, cholesterol, BMI, HTN
  2. OR1: Crude. OR2: Adjusted for age, gender, education and income. OR3: Adjusted for age, gender, education, income, duration of disease, Cholesterol, BMI, HTN, and FBS